Georgia Scores First 2026 Verbal From Backstroker Virginia Hinds NEW COMMIT: The University of Georgia has opened its Class ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
Chiquita, in partnership with KeyGene, MusaRadix and Wageningen University and Research announces the introduction of Yelloway One ...
The FDA approves BMY's differentiated schizophrenia treatment for adults and broadens its diverse portfolio. Shares gain.
The opposition research dossier compiled by Donald Trump's campaign on J.D. Vance was published online after hackers – ...
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb, combines ...
An estimated one-third of patients with major depressive disorder have treatment-resistant depression (TRD), characterized by ...
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
Gillian McDonald was diagnosed with triple negative inflammatory breast cancer at age 33. Learn how she navigated her care ...
Interview: U.S.A. swim team captain Ryan Murphy on his Paris Olympic wins and silver lining found in the 200-meter back ...
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback